BRPI1013539A2 - composição farmacêutica sublingual compreendendo um óleo neutro - Google Patents

composição farmacêutica sublingual compreendendo um óleo neutro

Info

Publication number
BRPI1013539A2
BRPI1013539A2 BRPI1013539A BRPI1013539A BRPI1013539A2 BR PI1013539 A2 BRPI1013539 A2 BR PI1013539A2 BR PI1013539 A BRPI1013539 A BR PI1013539A BR PI1013539 A BRPI1013539 A BR PI1013539A BR PI1013539 A2 BRPI1013539 A2 BR PI1013539A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
neutral oil
sublingual pharmaceutical
sublingual
neutral
Prior art date
Application number
BRPI1013539A
Other languages
English (en)
Portuguese (pt)
Inventor
Clive Booles
Original Assignee
Londonpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2009/050416 external-priority patent/WO2010122276A1/en
Priority claimed from GB0906977A external-priority patent/GB2469792A/en
Application filed by Londonpharma Ltd filed Critical Londonpharma Ltd
Publication of BRPI1013539A2 publication Critical patent/BRPI1013539A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1013539A 2009-04-23 2010-04-23 composição farmacêutica sublingual compreendendo um óleo neutro BRPI1013539A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2009/050416 WO2010122276A1 (en) 2009-04-23 2009-04-23 Drug delivery
GB0906977A GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery
PCT/GB2010/050671 WO2010122355A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil

Publications (1)

Publication Number Publication Date
BRPI1013539A2 true BRPI1013539A2 (pt) 2016-04-12

Family

ID=42236683

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013539A BRPI1013539A2 (pt) 2009-04-23 2010-04-23 composição farmacêutica sublingual compreendendo um óleo neutro

Country Status (15)

Country Link
US (1) US20120058158A1 (https=)
EP (1) EP2421503A1 (https=)
JP (1) JP2012524771A (https=)
CN (1) CN102458358A (https=)
AU (1) AU2010240653A1 (https=)
BR (1) BRPI1013539A2 (https=)
CA (1) CA2756879A1 (https=)
IL (1) IL215454A (https=)
MX (1) MX2011010835A (https=)
MY (1) MY167918A (https=)
NZ (1) NZ595467A (https=)
RU (1) RU2011139638A (https=)
SG (1) SG175160A1 (https=)
WO (1) WO2010122355A1 (https=)
ZA (1) ZA201107089B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
US20130254139A1 (en) * 2012-03-21 2013-09-26 Xiaoguang Lei Systems and methods for building a universal intelligent assistant with learning capabilities
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US10376586B2 (en) 2016-02-16 2019-08-13 Entourage Bioscience, LLC Method and compositions for solubilizing non-polar constituents
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
KR20230137362A (ko) * 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
KR102442753B1 (ko) * 2016-12-26 2022-09-16 셀릭스 바이오 프라이빗 리미티드 만성 통증 치료를 위한 화합물
IL313551A (en) * 2017-09-27 2024-08-01 Aquestive Therapeutics Inc Enhanced delivery epinephrine and prodrug compositions
EP3902523A1 (en) 2018-12-29 2021-11-03 3M Innovative Properties Company Oral articles and methods of use
WO2020136606A1 (en) 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
HUE073311T2 (hu) * 2020-03-31 2026-01-28 Remicine Ip B V Hiperinflammatorikus szindróma kezelése
EP4422607A4 (en) 2021-10-25 2025-09-03 Aquestive Therapeutics Inc ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4869899A (en) * 1986-03-10 1989-09-26 Walter Burghart Pharmaceutical preparation and process for producing the same
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
DK1361864T3 (en) * 2001-02-14 2014-03-03 Gw Pharma Ltd FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
RU2432950C2 (ru) * 2006-01-25 2011-11-10 Инсис Терапьютикс Инк. Подъязычный спрей на основе фентанила
CA2698752A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
NZ595469A (en) * 2009-04-23 2013-10-25 Londonpharma Ltd Sublingual spray formulation comprising dihydroartemesinin

Also Published As

Publication number Publication date
MY167918A (en) 2018-09-27
IL215454A (en) 2014-11-30
MX2011010835A (es) 2012-05-08
ZA201107089B (en) 2012-12-27
CN102458358A (zh) 2012-05-16
AU2010240653A1 (en) 2011-10-20
NZ595467A (en) 2013-08-30
WO2010122355A1 (en) 2010-10-28
RU2011139638A (ru) 2013-05-27
JP2012524771A (ja) 2012-10-18
US20120058158A1 (en) 2012-03-08
CA2756879A1 (en) 2010-10-28
IL215454A0 (en) 2011-12-29
EP2421503A1 (en) 2012-02-29
SG175160A1 (en) 2011-11-28

Similar Documents

Publication Publication Date Title
BRPI1013539A2 (pt) composição farmacêutica sublingual compreendendo um óleo neutro
PL2475352T3 (pl) Kompozycja zawierająca palmitoiloetanoloamid poddany ultramikronizacji
EP2412790A4 (en) Gear oil composition
FR2944289B1 (fr) Composition huileuse volatile
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (en) Compositions
SMT201600307B (it) Composizione liposomiale
UY33161A (es) Composiciones plaguicidas
DOP2011000396A (es) Composiciones novedosas
BRPI1013588A2 (pt) composição
BRPI1012539A2 (pt) composições farmacêuticas
DK3097925T3 (da) Farmaceutisk sammensætning
BR112012003977A2 (pt) composições que induzem ajuda de célula t
BR112012005242A2 (pt) composição de óleo anticorrosivo
BRPI1006505A2 (pt) embalagem
BRPI1004940A2 (pt) composição farmacêutica
BRPI1015474A2 (pt) composição
BRPI1010690A2 (pt) composições
BRPI1015939A2 (pt) composição farmacêutica
IT1394400B1 (it) Composizioni farmaceutiche
DK2339208T3 (da) Gear
BRPI0923528A2 (pt) engrenagem intermediária
BRPI1005290A2 (pt) composição
BR112012001340A2 (pt) composições farmacêuticas
BR112012003149A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL